Several oncology companies announced key trial milestones this week across the landscape of both blood cancers and solid ...

For years, scientists have hoped to harness the immune system to attack cancer using a group of drugs known as CD40 agonist ...

A cardiac device trial published in eClinicalMedicine shows that improving enrollment of females in such trials can better ...

For decades, dentists and scientists have dreamed of helping people regrow lost teeth. Now, thanks to remarkable advances in ...

Synthetic generation replicates key clinical patterns from real-world data, enabling valid analyses with fewer patients.

Private equity firm THL Partners has agreed to buy a majority stake in Headlands Research, a U.S.-based network of clinical ...

At the end of the day, there is no sure thing in a clinical trial from a patient’s point of view. There are certainly diseases that are life-threatening, and those patients are sometimes willing ...

A phase II clinical trial is larger and is used to determine if the treatment is effective. Depending on the prevalence of the type of cancer the treatment is designed for, up to 100 patients may ...

All trials have some level of risk, but the risk may be small and vary from trial to trial. Both risks and benefits of a clinical trial depend on your cancer and how your treatment is going.